Skip to main content
Market intelligence
URGNHealthcare

UroGen Pharma Ltd insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 22, 2026Mark SchoenbergChief Medical OfficerSale10,000$35.01$350,100
Jun 8, 2026Mark SchoenbergChief Medical OfficerSale5,222$27.30$142,561
May 8, 2026Mark SchoenbergChief Medical OfficerSale10,000$30.00$300,000